| Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease. | |
| | |
MedLine Citation:
|
PMID: 23183429 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Asymptomatic multiple myeloma (AMM) is characterized by a constant risk of progression to symptomatic myeloma. To evaluate previously recognized risk factors and to identify high-risk features we analyzed 96 patients with AMM and at least 18 months of follow-up. The progression rate at 1,2, and 3 years was 8%, 15% and 26%, respectively, and the projected 5-year progression rate was 38%. Extensive bone marrow (BM) infiltration, abnormal free light chain (FLC) ratio and serum monoclonal (M)-protein3 gr/dl were the most significant factors for progression, whereas the type of heavy (IgG vs IgA) or light chain or immunoparesis of the uninvolved immunoglobulins were not. Abnormal marrow signal of magnetic resonance imaging of the spine was associated with a significant risk of progression (median 15 months, P=0.001). Extensive BM infiltration 60% (hazard ratio, HR: 13.7, P<0.001) and FLC ratio100 (HR: 9, P=0.003) independently identified a 'very high-risk' group, which included 12.5% of patients with AMM and who progressed 18 months from initial diagnosis. Development of anemia and/or lytic bone lesions were the most common features of symptomatic progression. In conclusion, there is a subgroup of patients who have a substantial risk of progression to symptomatic disease that can be detected at diagnosis (either by extensive BM infiltration60% or FLC ratio100) and may be considered for immediate treatment.Leukemia advance online publication, 27 November 2012; doi:10.1038/leu.2012.309. |
| | |
Authors:
|
E Kastritis; E Terpos; L Moulopoulos; M Spyropoulou-Vlachou; N Kanellias; E Eleftherakis-Papaiakovou; M Gkotzamanidou; M Migkou; M Gavriatopoulou; M Roussou; A Tasidou; M A Dimopoulos |
Related Documents
:
|
3654719 - Sexual satisfaction in burn patients. 17980969 - When and how to perform aeromedical transport of critically burned patients in northwes... 2019159 - Peripheral vascular tone in sepsis. 20890859 - Can hyperbaric oxygenation therapy (hot) modify the blood testosterone concentration? 10902859 - Cardiac troponin i: a marker for post-burn cardiac injury. 451819 - Measurement of toe temperature for assessing the severity of acute circulatory failure. 15829169 - Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic late... 2798729 - Delusions of fatal contagion among refugee patients. 4047919 - Restoration of walking in patients with incomplete spinal cord injuries by use of surfa... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-11-06 |
Journal Detail:
|
Title: Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K Volume: - ISSN: 1476-5551 ISO Abbreviation: Leukemia Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-11-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8704895 Medline TA: Leukemia Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma.
Next Document: Replacement R164H and V240H by site-directed mutagenesis of TEM-149 ESBL: kinetic analysis of TEM-14...